Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study
Diabetic Medicine · 2025
DOI: 10.1111/dme.70119 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Lisa Chu und 1 weiteren Autor:innen. Beteiligte Einrichtung: LMC Diabetes & Endocrinology, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose Self-Monitoring, Blood Glucose, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dexcom.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
This study investigated the real‐world clinical outcomes of switching from intermittently scanned continuous glucose monitoring (isCGM) to real‐time CGM (rtCGM) in adults with type 1 diabetes (T1D) from a large Canadian speciality care population.
Methods
This retrospective observational study examined data from January 1, 2018, through July 31, 2023, in the Canadian LMC Diabetes Registry. The analysis measured 6–12‐month change in HbA1c in adults with T1D who switched from isCGM to rtCGM and compared changes to a propensity score‐matched isCGM cohort. Changes in number of hypoglycaemic events, CGM metrics, body weight, and total daily dose (TDD) of insulin were also evaluated at 6–12‐month follow‐up.
Results
The full T1D rtCGM switch cohort comprised of 136 adults (mean: age 43 years, diabetes duration 20.9 years, baseline HbA1c 67 mmol/mol [8.2%]). For the full cohort, HbA1c was significantly lower at follow‐up compared to baseline (∆‐7 mmol/mol [∆‐0.6%], p < 0.001). The propensity score‐matched subset ( n = 84) of these participants had a greater HbA1c reduction compared to the matched isCGM cohort ( n = 84; adjusted mean difference, 5 mmol/mol [0.5%]; p = 0.002). The matched rtCGM switch subset had significantly higher time in range 3.9–10.0 mmol/L and lower time above range >10.0 mmol/L, time below range
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LMC Diabetes & Endocrinology, Toronto, Ontario, Canada.
ORCID-Profile: Lisa Chu
Förderung
- Dexcom
Zitieren
APA
Chu, L., & Abitbol, A. (2025). Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study. Diabetic Medicine. https://doi.org/10.1111/dme.70119
Vancouver
Chu L, Abitbol A. Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study. Diabetic Medicine. 2025. doi:10.1111/dme.70119
BibTeX
@article{Chu2025,
author = {Chu, Lisa and Abitbol, Alexander},
title = {Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study},
journal = {Diabetic Medicine},
year = {2025},
doi = {10.1111/dme.70119}
}
EUVIMED